Qbeco    (DrugBank: -)

1 disease
告示番号疾患名(ページ内リンク)臨床試験数
96クローン病2

96. クローン病 [臨床試験数:2,209,薬物数:1,276(DrugBank:240),標的遺伝子数:166,標的パスウェイ数:210
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
2 / 2,209 trials found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03472690
(ClinicalTrials.gov)
June 25, 20188/3/2018QBECO SSI for Clinical and Endoscopic Remission in Moderate to Severe Crohn's DiseaseA Phase 2, Multi-center, Randomized, Double-Blind, Placebo-Controlled Study of QBECO SSI for the Induction and Maintenance of Clinical and Endoscopic Remission in Subjects With Moderate to Severe Crohn's DiseaseCrohn DiseaseBiological: QBECO-SSI;Other: PlaceboQu Biologics Inc.NULLActive, not recruiting18 YearsN/AAll20Phase 2Canada
2NCT01809275
(ClinicalTrials.gov)
March 20138/3/2013Safety and Treatment Effect of QBECO in Moderate to Severe Crohn's DiseaseA Phase 1/2 Randomized, Placebo-Controlled, Double-Blind Study of the Induction of Clinical Response and Remission by QBECO in Subjects With Moderate to Severe Crohn's DiseaseCrohn's Disease;Inflammatory Bowel DiseaseDrug: QBECO;Drug: PlaceboQu Biologics Inc.NULLCompleted18 YearsN/ABoth68Phase 1;Phase 2Canada